Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other financing activities (2016 - 2019)

Organogenesis Holdings (ORGO) has 4 years of Other financing activities data on record, last reported at $924000.0 in Q3 2019.

  • For Q3 2019, Other financing activities rose 1908.7% year-over-year to $924000.0; the TTM value through Sep 2019 reached $2.7 million, up 337.83%, while the annual FY2020 figure was $5.7 million, 90.25% up from the prior year.
  • Other financing activities reached $924000.0 in Q3 2019 per ORGO's latest filing, up from $849000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $924000.0 in Q3 2019 and bottomed at $9000.0 in Q1 2018.
  • Average Other financing activities over 4 years is $366365.4, with a median of $294019.0 recorded in 2016.
  • Peak YoY movement for Other financing activities: plummeted 97.9% in 2018, then soared 8911.11% in 2019.
  • A 4-year view of Other financing activities shows it stood at $294019.0 in 2016, then soared by 47.75% to $434422.0 in 2017, then plummeted by 78.59% to $93000.0 in 2018, then soared by 893.55% to $924000.0 in 2019.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $924000.0 in Q3 2019, $849000.0 in Q2 2019, and $811000.0 in Q1 2019.